Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 462401 - 462420 out of 485193 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01XE33) palbociclib | IBRANCE 125MG CAP | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XE33) palbociclib | IBRANCE 125MG CAP | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XE33) palbociclib | IBRANCE 75MG CAP | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XE33) palbociclib | IBRANCE 75MG CAP | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XE33) palbociclib | IBRANCE 75MG TAB,ORAL 3X7 U/D | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XE34) tivozanib | FOTIVDA 1.34MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | AveoPharmaceuticalsInc.;DBAAVEOOncology |
| USA | (L01XE38) Cobimetinib | COTELLIC 20MG TAB | 63 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | GenentechUSA,Inc. |
| USA | (L01XE42) ribociclib | KISQALI FCT 200MG TAB, 21(200MG) DAILY PKT | 1X21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01XE42) ribociclib | KISQALI FCT 200MG TAB, 21(200MG) DAILY PKT | 1X21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01XE42) ribociclib | KISQALI FCT 200MG TAB, 42 (400MG) DAILY PKT | 3X14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01XE42) ribociclib | KISQALI FCT 200MG TAB, 42 (400MG) DAILY PKT | 3X14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01XE42) ribociclib | KISQALI FCT 200MG TAB, 63(600MG) DAILY PKT | 3X21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01XE42) ribociclib | KISQALI FCT 200MG TAB, 63(600MG) DAILY PKT | 3X21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01XE42) ribociclib | KISQALI FEMARA CO-PACK | 70 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01XE42) ribociclib | KISQALI FEMARA CO-PACK | 91 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01XE42) ribociclib | KISQALI FEMARA CO-PACK | 49 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01XE42) ribociclib | KISQALI FEMARA CO-PACK | 70 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01XE42) ribociclib | KISQALI FEMARA CO-PACK | 91 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01XE43) brigatinib | ALUNBRIG 30MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01XE43) brigatinib | ALUNBRIG 30MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | TakedaPharmaceuticalsAmerica,Inc. |
Pages
